These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27689203)

  • 1. Magnetic Nanoparticles for Hepatocellular Carcinoma Diagnosis and Therapy.
    Ungureanu BS; Teodorescu CM; Săftoiu A
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):375-83. PubMed ID: 27689203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Nanotechnology in the Diagnosis and Therapy of Hepatocellular Carcinoma.
    Hou XY; Jiang G; Yang CS; Tang JQ; Wei ZP; Liu YQ
    Recent Pat Anticancer Drug Discov; 2016; 11(3):322-31. PubMed ID: 26955964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Magnetic Nanoparticle-based Molecular Probes for Hepatocellular Carcinoma Diagnosis and Therapy.
    Zhang Q; Wang S; Qiao R; Whittaker MR; Quinn JF; Davis TP; Li H
    Curr Pharm Des; 2018; 24(21):2432-2437. PubMed ID: 29788872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma.
    Elnaggar MH; Abushouk AI; Hassan AHE; Lamloum HM; Benmelouka A; Moatamed SA; Abd-Elmegeed H; Attia S; Samir A; Amr N; Johar D; Zaky S
    Semin Cancer Biol; 2021 Feb; 69():91-99. PubMed ID: 31421265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted arsenite-loaded magnetic multifunctional nanoparticles for treatment of hepatocellular carcinoma.
    Chi X; Zhang R; Zhao T; Gong X; Wei R; Yin Z; Lin H; Li D; Shan H; Gao J
    Nanotechnology; 2019 Apr; 30(17):175101. PubMed ID: 30654348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment.
    Singh A; Shafi S; Upadhyay T; Najmi AK; Kohli K; Pottoo FH
    Curr Top Med Chem; 2020; 20(20):1839-1854. PubMed ID: 32579503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy.
    Cai Y; Xu Y; Chan HF; Fang X; He C; Chen M
    Mol Pharm; 2016 Mar; 13(3):699-709. PubMed ID: 26808002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Application of Pre-clinical Animal Models to Optimise Nanoparticulate Drug Delivery for Hepatocellular Carcinoma.
    Zhang Z; Song L; Guo J
    Pharm Nanotechnol; 2018; 6(4):221-231. PubMed ID: 30277174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography].
    Pleger B; Beyer HK; Laufer U
    Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872
    [No Abstract]   [Full Text] [Related]  

  • 11. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
    Kim YK; Kim CS; Kwak HS; Lee JM
    J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicines: a theranostic approach for hepatocellular carcinoma.
    Usmani A; Mishra A; Ahmad M
    Artif Cells Nanomed Biotechnol; 2018 Jun; 46(4):680-690. PubMed ID: 28884605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection.
    Kou G; Wang S; Cheng C; Gao J; Li B; Wang H; Qian W; Hou S; Zhang D; Dai J; Gu H; Guo Y
    Biochem Biophys Res Commun; 2008 Sep; 374(2):192-7. PubMed ID: 18621023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma.
    Tanimoto A; Kuribayashi S
    Eur J Radiol; 2006 May; 58(2):200-16. PubMed ID: 16414230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
    Taratula O; Dani RK; Schumann C; Xu H; Wang A; Song H; Dhagat P; Taratula O
    Int J Pharm; 2013 Dec; 458(1):169-80. PubMed ID: 24091153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLinaS-g-PEG coated magnetic nanoparticles as a contrast agent for hepatocellular carcinoma diagnosis.
    Karahaliloglu Z; Kilicay E; Hazer B
    J Biomater Sci Polym Ed; 2020 Aug; 31(12):1580-1603. PubMed ID: 32460649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine.
    Kumar V; Rahman M; Gahtori P; Al-Abbasi F; Anwar F; Kim HS
    Expert Opin Drug Deliv; 2021 Jun; 18(6):673-694. PubMed ID: 33295218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in hepatocellular carcinoma-targeted nanoparticles.
    Liu X; Bai Y; Zhou B; Yao W; Song S; Liu J; Zheng C
    Biomed Mater; 2024 May; 19(4):. PubMed ID: 38697209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.